A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

Completed · Phase 2

Conditions studied: Glaucoma, Ocular Hypertension

In brief

This is a safety and efficacy study of fixed-combination bimatoprost and brimonidine compared with LUMIGAN® and ALPHAGAN® in patients with chronic glaucoma or ocular hypertension.

Key facts

Study ID

NCT01863953

Run by

Allergan

People needed

112

Starts

2013-06-01

Expected to finish

2013-12-01

Last updated by the study team

2015-01-26

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of ocular hypertension or glaucoma
• Requires intraocular pressure (IOP)-lowering therapy

You may not qualify if…

• Cataract surgery in one eye
• Ocular laser or intraocular surgery within 6 months
• Refractive surgery in either eye
• Anticipated use of contact lenses during the study
• Expected use of artificial tears during the study

Where it is running

• Study site — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.